Susan G. Komen Blog

Stories about breast cancer that can inspire and inform

Blog  |  Newsroom

Spotlight on Clinical Trials

All Posts

Advocacy

Cancer Updates

Care

Community

EmpowerED

Fundraising

Go Pink for the Cure

Know More

Komen Perspectives

MBC

News

Partnerships

Personal Stories

Real Talk

Research

ShareForCures

Spotlight on Clinical Trials

You're Not Too Young, Bestie

Shining a Spotlight on More Personalized Treatment Strategies for Metastatic ER-Positive/HER2-Negative Breast Cancer 

Spotlight on Clinical Trials

Personalized treatments are transforming the landscape of care for people living with ER-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer (MBC), by making therapy more effective and more tolerable. For those living with ER+/HER2- MBC, the standard first-line therapy usually includes hormone (endocrine) therapy paired with a CDK4/6 inhibitor. While these treatments work very well at first, […]

Shining a Spotlight on Promising Clinical Trials for Young Women 

Spotlight on Clinical Trials

In recent years, there has been a concerning rise in breast cancer diagnoses in young women (under age 50) in the United States. Although breast cancer is more commonly diagnosed in older women, more young women are being diagnosed, and some with aggressive tumors that require complex treatments. This is why clinical trials are especially […]

Shining a Spotlight on the Benefits of Complementary Therapies for Breast Cancer  

Spotlight on Clinical Trials

Complementary therapies are one of the most popular and rapidly growing options to help relieve some of the side effects of breast cancer treatment or the cancer itself. In fact, a recent national survey showed that 73% of breast cancer patients in the U.S. reported using at least one type of complementary therapy after their […]

Shining a Spotlight on More Effective Treatments for HER2+ MBC 

Spotlight on Clinical Trials

Despite important advances in breast cancer treatment, the disease can still find ways to outsmart even the best therapies. People living with HER2-positive metastatic breast cancer (HER2+ MBC) often respond well to treatments at first, with tumors shrinking or slowing down, but the effectiveness of these drugs doesn’t always last. Through the EmpowHER-303 clinical trial […]

A nurse walking through a 3D mammogram with a patient

Shining a Spotlight on the Benefits of 3D Mammograms 

Spotlight on Clinical Trials

Mammograms have been considered the gold standard for breast cancer screening for decades, but today’s mammogram screening recommendations don’t always offer a personalized approach. Today, most women may begin screenings at age 40, regardless of unique personal factors like ethnicity, family history or breast density. Researchers are exploring new ways to personalize breast cancer screening […]

Shining a Spotlight on the Promise of Exercise in the Management of MBC 

Research

Research has shown that exercise can improve overall survival, treatment tolerability and quality of life for women with early-stage breast cancer. But what about women who are living with metastatic breast cancer (MBC)? Through a clinical trial, researchers are exploring whether the addition of exercise to standard treatment could hold promise for women living with […]

Shining a Spotlight on Better Treatment Options for Metastatic ER-Positive/HER2-Negative Breast Cancer 

Research

Researchers are always seeking safer, more effective treatment options for breast cancer patients through clinical trials, with the hope that these new treatments could also be more tolerable. For people living with metastatic estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer, the hormone therapy fulvestrant is the standard treatment for […]

Shining a Spotlight on the Unmet Needs of Patients with Advanced ER-Positive / HER2-Negative Breast Cancer 

Research

For breast cancer researchers, one of the biggest goals of a clinical trial is to address the unmet needs of people living with advanced breast cancer. Advanced breast cancer is difficult to cure or control with treatment. The cancer may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body, i.e. bones, lungs, brain, or liver.  Patients with advanced breast cancer need more treatment options.  

Spotlight on Clinical Trials: Shining a Light on Breast Cancer Disparities

Research

“In the Black community, there’s a stigma about treatment, clinical trials and research. We have to understand that there’s not enough data to help us if we get sick. There’s not enough data to create treatments that will help us. We need to participate in clinical trials.” Sharon Elmore-Anderson Patient Advocate Living with Metastatic IBC